# Diagnostic Grifols, S.A. – FDA Inspection, Nov 14, 2016

Source: https://www.keypedia.com/records/fda_inspections/diagnostic-grifols-sa/dd9b5ada-6b05-41bf-9251-2b32a99ff4fc
Source feed: FDA_Inspections

> FDA inspection 1004513 of Diagnostic Grifols, S.A., November 14, 2016. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1004513
- Company Name: Diagnostic Grifols, S.A.
- Inspection Date: 2016-11-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1273855 - 2025-05-09
- [FDA Inspection 1082479 - 2018-12-14](https://www.keypedia.com/records/fda_inspections/diagnostic-grifols-sa/b5295f18-4978-481b-95f5-9bed1160f803)
- FDA Inspection 1031526 - 2017-07-20
- [FDA Inspection 1002584 - 2017-02-16](https://www.keypedia.com/records/fda_inspections/diagnostic-grifols-sa/64042802-18e9-480f-84ff-b4660e0ee01e)
- FDA Inspection 919194 - 2015-01-30

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/simone-e-pitts/e405f1fc-4aff-4202-b216-ddbdc342d108)

Company: https://www.keypedia.com/companies/diagnostic-grifols-sa/84fde072-c535-4714-9da4-b905c76e4710

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d